Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna M G Pasmooij

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
The Journal of Investigative Dermatology|March 27, 2018
Topical Gentamicin for the Treatment of Genetic Skin DiseasesAnna M G Pasmooij
The Journal of Investigative Dermatology|February 14, 2012
Realm of revertant mosaicism expandingMarcel F Jonkman, Anna M G Pasmooij
Methods in Molecular Biology (Clifton, N.J.)|January 18, 2013
Analysis of cutaneous somatic mosaicismAnna M G Pasmooij, Marcel F Jonkman
Discovery Medicine|October 2, 2012
Revertant mosaicism in heritable skin diseases: mechanisms of natural gene therapyAnna M G Pasmooij, Marcel F Jonkman, Jouni Uitto
Journal of the American Academy of Dermatology|November 2, 2013
Successful therapeutic transplantation of revertant skin in epidermolysis bullosaAntoni Gostyński, Anna M G Pasmooij, Marcel F Jonkman
Frontiers in Medicine|May 23, 2022
Evaluation of Companion Diagnostics in Scientific Advice and Drug Marketing Authorization Applications by the European Medicines AgencyMarc Maliepaard, Priscilla Nibi, Gabrièlla Nibi, et al.
Frontiers in Medicine|July 19, 2021
The Use of Remote Monitoring Technologies: A Review of Recent Regulatory Scientific Advices, Qualification Opinions, and Qualification Advices Issued by the European Medicines AgencyMarieke J H J Dekker, Pieter Stolk, Anna M G Pasmooij
The Journal of Investigative Dermatology|February 10, 2012
Natural gene therapy may occur in all patients with generalized non-Herlitz junctional epidermolysis bullosa with COL17A1 mutationsAnna M G Pasmooij, Miranda Nijenhuis, Renske Brander, et al.
Biomedicines|September 23, 2022
Revertant Mosaicism in Genodermatoses: Natural Gene Therapy Right before Your EyesPeter C van den Akker, Maria C Bolling, Anna M G Pasmooij
Nucleic Acid Therapeutics|March 13, 2026
Reduced Genotoxicity Testing Is Possible for Noncoding Oligonucleotide-Based Therapeutics Containing Well-Characterized Modifications: A European Regulatory PerspectiveClara Stock, Britt Duijndam, Christine L E Siezen, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
The Journal of Investigative Dermatology|March 27, 2018
Topical Gentamicin for the Treatment of Genetic Skin DiseasesAnna M G Pasmooij
The Journal of Investigative Dermatology|February 14, 2012
Realm of revertant mosaicism expandingMarcel F Jonkman, Anna M G Pasmooij
Methods in Molecular Biology (Clifton, N.J.)|January 18, 2013
Analysis of cutaneous somatic mosaicismAnna M G Pasmooij, Marcel F Jonkman
Discovery Medicine|October 2, 2012
Revertant mosaicism in heritable skin diseases: mechanisms of natural gene therapyAnna M G Pasmooij, Marcel F Jonkman, Jouni Uitto
Journal of the American Academy of Dermatology|November 2, 2013
Successful therapeutic transplantation of revertant skin in epidermolysis bullosaAntoni Gostyński, Anna M G Pasmooij, Marcel F Jonkman
Frontiers in Medicine|May 23, 2022
Evaluation of Companion Diagnostics in Scientific Advice and Drug Marketing Authorization Applications by the European Medicines AgencyMarc Maliepaard, Priscilla Nibi, Gabrièlla Nibi, et al.
Frontiers in Medicine|July 19, 2021
The Use of Remote Monitoring Technologies: A Review of Recent Regulatory Scientific Advices, Qualification Opinions, and Qualification Advices Issued by the European Medicines AgencyMarieke J H J Dekker, Pieter Stolk, Anna M G Pasmooij
The Journal of Investigative Dermatology|February 10, 2012
Natural gene therapy may occur in all patients with generalized non-Herlitz junctional epidermolysis bullosa with COL17A1 mutationsAnna M G Pasmooij, Miranda Nijenhuis, Renske Brander, et al.
Biomedicines|September 23, 2022
Revertant Mosaicism in Genodermatoses: Natural Gene Therapy Right before Your EyesPeter C van den Akker, Maria C Bolling, Anna M G Pasmooij
Nucleic Acid Therapeutics|March 13, 2026
Reduced Genotoxicity Testing Is Possible for Noncoding Oligonucleotide-Based Therapeutics Containing Well-Characterized Modifications: A European Regulatory PerspectiveClara Stock, Britt Duijndam, Christine L E Siezen, et al.
Pageof 6